A pilot randomised controlled trial of electrical and magnetic stimulation against sham to mitigate intensive-care-unit-acquired weakness after trauma

niversity of Birmingham (UK)0 sites30 target enrollmentSeptember 19, 2013

Overview

No summary available.

Registry

who.int

Start Date

September 19, 2013

End Date

April 1, 2014

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity of Birmingham (UK)

•Patients must:
•1\. be aged 16 years old or over
•2\. have been able to transfer independently from bed to chair prior to injury
•3\. be admitted to the Critical Care Unit at Queen Elizabeth Hospital, Birmingham as result of traumatic injury
•4\. have an anticipated length of stay of at least 2 weeks
•5\. give consent (or, if lacking capacity at screening, have a personal or professional consultee indicate that they would be likely to give consent were they not lacking capacity)
•Target Gender: Male \& Female

•Patients must not:
•1\. refuse to allow their GP to be informed of participation
•2\. have known systemic neuromuscular disease (e.g. Guillain Barré Syndrome) at ICU admission
•3\. have known pathology affecting the brain, causing weakness (e.g. stroke or bleeding in the brain) at the time of Critical Care Unit admission
•4\. have any pacemaker (e.g., cardiac, diaphragm, gastric) or implanted cardiac defibrillator, neurostimulator, intracardiac line or cochlear implant
•5\. have any metallic implants or foreign bodies in the areas to be stimulated
•6\. have any metal (other than titanium) in the head or brain
•7\. have known or suspected malignancy in any limb
•8\. be pregnant
•9\. have a body mass index \=35 kg/m2